Study Name: A Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations and Change in Lung Function in
26 locations found
- Teva Investigational Site 58
Location: Scottsdale, Arizona
- Teva Investigational Site 61
Location: Los Angeles, California
- Teva Investigational Site 37
Location: Orange, California
- Teva Investigational Site 56
Location: San Diego, California
- Teva Investigational Site 34
Location: Colorado Springs, Colorado
- Teva Investigational Site 52
Location: Debary, Florida
- Teva Investigational Site 55
Location: Miami, Florida
- Teva Investigational Site 18
Location: Valrico, Florida
- Teva Investigational Site 49
Location: Lexington, Kentucky
- Teva Investigational Site 65
Location: Louisville, Kentucky
- Teva Investigational Site 51
Location: Boston, Massachusetts
- Teva Investigational Site 74
Location: St. Louis, Missouri
- Teva Investigational Site 35
Location: Missoula, Montana
- Teva Investigational Site 64
Location: Boys Town, Nebraska
- Teva Investigational Site 60
Location: Bronx, New York
- Teva Investigational Site 68
Location: Rochester, New York
- Teva Investigational Site 30
Location: Winston-Salem, North Carolina
- Teva Investigational Site 31
Location: Cincinnati, Ohio
- Teva Investigational Site 62
Location: Columbus, Ohio
- Teva Investigational Site 50
Location: Oklahoma City, Oklahoma
- Teva Investigational Site 66
Location: Altoona, Pennsylvania
- Teva Investigational Site 32
Location: Nashville, Tennessee
- Teva Investigational Site 63
Location: Boerne, Texas
- Teva Investigational Site 72
Location: Houston, Texas
- Teva Investigational Site 38
Location: Richmond, Virginia
- Teva Investigational Site 33
Location: Madison, Wisconsin
|